alcom Fraser and Mary Dimou, managing partner and general partner, Nàdarra Ventures.
Posted in General

Nàdarra Ventures makes $20-million first close in new Canadian biotech fund

Backed by Farm Credit Canada and Natural Products Canada, fund target is $50 million. A new venture capital fund meant to tackle food insecurity…

Continue Reading Nàdarra Ventures makes $20-million first close in new Canadian biotech fund
Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit
Posted in General

Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit

Montréal startup’s backers include Theodorus, Eurêka, BKR Capital, Sandpiper, and ACET Capital. Clinical trials can be time-consuming, expensive, and suffer poor success rates. Using…

Continue Reading Simmunome secures $2 million to make clinical trials more efficient with AI |BetaKit
Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
Posted in General

Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm

Brian O’Callaghan to lead Toronto firm as founder transitions to chief innovation officer. Toronto-based artificial intelligence (AI) drug development startup Deep Genomics has hired…

Continue Reading Deep Genomics adds life sciences veteran as CEO to support its evolution into biopharma firm
recursion logo on sign outside of brick building
Posted in General

After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery

Recursion, a US-based biotech firm, opened a new Canadian headquarters in Toronto last month. Computing giant Nvidia has invested $50 million USD in Recursion…

Continue Reading After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery
H|T: The Healthtech Times – Canada’s latest big biotech exit
Posted in General

H|T: The Healthtech Times – Canada’s latest big biotech exit

Plus: Google Lens can now search for skin conditions. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the…

Continue Reading H|T: The Healthtech Times – Canada’s latest big biotech exit
AbCellera SIF funding announcement
Posted in General

AbCellera receives $300 million in combined government funding for biotech campus

The $701-million project aims to build a “state-of-the-art” campus, add 400 jobs. Vancouver-based biotechnology firm AbCellera has received significant provincial and federal backing in…

Continue Reading AbCellera receives $300 million in combined government funding for biotech campus
American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence
Posted in General

American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence

“Policymakers should look to understand why so many promising tech companies choose to sell themselves.” An American biotech company is acquiring Cyclica and Valence…

Continue Reading American biotech Recursion acquires two Canadian AI drug-discovery companies, Cyclica and Valence
MaRS discovery district
Posted in General

MaRS, adMare BioInnovations launch new biotech accelerator for early-stage ventures

New accelerator will provide valuable lab space, mentorship. A new Toronto-based accelerator is opening to help early-stage Canadian biotech ventures overcome fundamental barriers, such…

Continue Reading MaRS, adMare BioInnovations launch new biotech accelerator for early-stage ventures
Meet the biotech startup that received funding from both Garage Capital and Maple Leaf Foods
Posted in General

Meet the biotech startup that received funding from both Garage Capital and Maple Leaf Foods

Kitchener-Waterloo-based Evolved Meats claims that from only a few cells it can grow “whole cuts of real meat from any animal.” Evolved Meats (formerly…

Continue Reading Meet the biotech startup that received funding from both Garage Capital and Maple Leaf Foods